Peptide BPC-157
US$ 20.12
nac glutathion contre indication N-Acétylcystéine 600 mg : pure pour N-Acétyl Cystéine (NAC) 600 mg
Description
These findings suggest that HIF-1 may be a potential therapeutic target for ameliorating excessive inflammation (Yu et al., 2024)
10.1080/13697137.2019.1574738 35 GonzalezF.ConsidineR
428 Based on these findings and the identified crosstalk mechanisms between HGF/c-Met and Wnt signaling, targeting crosstalk signaling pathways may hold promise as an effective therapeutic approach for organ I/R injury
The trial period was 12 weeks and the dose was 60 mg/kg/day in three doses with a maximum of 4,200 mg/day
